Progyny Inc. (PGNY)
| Bid | 21.78 |
| Market Cap | 1.89B |
| Revenue (ttm) | 1.16B |
| Net Income (ttm) | 54.09M |
| EPS (ttm) | 0.57 |
| PE Ratio (ttm) | 38.75 |
| Forward PE | 14.57 |
| Analyst | Hold |
| Ask | 22.21 |
| Volume | 890,350 |
| Avg. Volume (20D) | 1,982,998 |
| Open | 22.15 |
| Previous Close | 21.86 |
| Day's Range | 21.92 - 22.32 |
| 52-Week Range | 13.39 - 38.98 |
| Beta | 1.42 |
About PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the me...
Analyst Forecast
According to 11 analyst ratings, the average rating for PGNY stock is "Hold." The 12-month stock price forecast is $23, which is an increase of 4.12% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago · seekingalpha.com
The Bottom Fishing Club: Progyny Reverses On Heavy Insider BuyingProgyny shares have plummeted nearly 80% from 2021's peak, but management optimism and insider buying in December signal a potential turnaround during 2025. PGNY's valuation is deeply discounted, with...